antipyrine has been researched along with Acute Ischemic Stroke in 3 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the hypothesis that edaravone reduces functional dependence in ischemic stroke patients." | 9.22 | Edaravone for acute ischemic stroke - Systematic review with meta-analysis. ( Afreixo, V; Fidalgo, M; Gregório, H; Gregório, T; Magalhães, P; Ricardo Pires, J; Viseu, I, 2022) |
| " Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) is a clinically approved cerebroprotective agent against ischemic stroke and amyotrophic lateral sclerosis, while new formulations that enable improvement of its physicochemical properties and biodistribution are desired." | 8.31 | Development of Edaravone Ionic Liquids and Their Application for the Treatment of Cerebral Ischemia/Reperfusion Injury. ( Fukuta, T; Ikeda-Imafuku, M; Iwao, Y, 2023) |
| "To test the hypothesis that edaravone reduces functional dependence in ischemic stroke patients." | 5.22 | Edaravone for acute ischemic stroke - Systematic review with meta-analysis. ( Afreixo, V; Fidalgo, M; Gregório, H; Gregório, T; Magalhães, P; Ricardo Pires, J; Viseu, I, 2022) |
| " Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) is a clinically approved cerebroprotective agent against ischemic stroke and amyotrophic lateral sclerosis, while new formulations that enable improvement of its physicochemical properties and biodistribution are desired." | 4.31 | Development of Edaravone Ionic Liquids and Their Application for the Treatment of Cerebral Ischemia/Reperfusion Injury. ( Fukuta, T; Ikeda-Imafuku, M; Iwao, Y, 2023) |
| "Edaravone has been widely used in the treatment of acute ischemic stroke." | 4.12 | Neuroprotection of Oral Edaravone on Middle Cerebral Artery Occlusion in Rats. ( Luo, HY; Parikh, A; Xiong, YX; Ye, QY; Zhao, LQ; Zhou, XF, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, LQ | 1 |
| Parikh, A | 1 |
| Xiong, YX | 1 |
| Ye, QY | 1 |
| Zhou, XF | 1 |
| Luo, HY | 1 |
| Fidalgo, M | 1 |
| Ricardo Pires, J | 1 |
| Viseu, I | 1 |
| Magalhães, P | 1 |
| Gregório, H | 1 |
| Afreixo, V | 1 |
| Gregório, T | 1 |
| Fukuta, T | 1 |
| Ikeda-Imafuku, M | 1 |
| Iwao, Y | 1 |
1 review available for antipyrine and Acute Ischemic Stroke
| Article | Year |
|---|---|
Edaravone for acute ischemic stroke - Systematic review with meta-analysis.
Topics: Adult; Antipyrine; Brain Ischemia; Edaravone; Free Radical Scavengers; Humans; Intracranial Hemorrha | 2022 |
2 other studies available for antipyrine and Acute Ischemic Stroke
| Article | Year |
|---|---|
Neuroprotection of Oral Edaravone on Middle Cerebral Artery Occlusion in Rats.
Topics: Animals; Antipyrine; Edaravone; Free Radical Scavengers; Infarction, Middle Cerebral Artery; Ischemi | 2022 |
Development of Edaravone Ionic Liquids and Their Application for the Treatment of Cerebral Ischemia/Reperfusion Injury.
Topics: Animals; Antipyrine; Brain Ischemia; Edaravone; Free Radical Scavengers; Ionic Liquids; Ischemic Str | 2023 |